Close Menu
Varta24 Business
    What's Hot

    Rising Borrowing Costs Signal Funding Risks for Global AI Expansion: Jefferies Report

    October 17, 2026

    Househelp@₹100: The 10-Minute Boom Can’t Sweep Aside a Math Problem

    October 17, 2026

    Prem Watsa’s Grand Vision: Riding India’s Decade of Growth Through the IDBI Bank Acquisition

    October 17, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Varta24 BusinessVarta24 Business
    Subscribe
    • Home
    • Top News
    • Companies
    • Finance
    • Insurance
    • Markets
    • Technology
    • World News
    Varta24 Business
    Home»Markets»Stock Radar: Star Health stock slips from July 2026 52-week high, but bounces back from 50-DMA; time to buy?
    Markets

    Stock Radar: Star Health stock slips from July 2026 52-week high, but bounces back from 50-DMA; time to buy?

    Aruna KaimBy Aruna KaimAugust 14, 2026No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Star Health stock is showing a positive technical setup for a comeback. Experts suggest buying the stock for a target above 600 levels. The stock bounced back after testing its 50-day moving average earlier. It is also holding above the Ichimoku cloud, indicating improved trend strength.

    Star Health & Allied Insurance Company Ltd, part of the general insurance company space, bounced back after testing 50-DMA on the daily charts which suggest bulls are trying to make a comeback. Short-term traders can look to buy the stock for a target above 600 levels in the next 2-3 weeks, suggest experts. The stock hit a high of Rs 624 on 30th July 2026, but it failed to hold the momentum. It closed at Rs 583 on 12th August 2026, which translates to a key consolidation zone offering a favorable risk-reward setup.

    Key Technical Factors Supporting the Bullish Setup

    1. Rebound from 50-Day Moving Average (50-DMA):

      After pulling back from its 52-week high of ₹624.90 reached in late July 2026, the stock found strong buying interest near its 50-DMA support zone (~₹580 level). A bounce from this critical moving average indicates that institutional buyers are stepping in on dips.

    2. Holding Above Ichimoku Cloud:

      On the daily charts, the price structure continues to float above the Ichimoku Cloud indicator, signalling that the underlying medium-term trend remains firmly bullish.

    3. Momentum Indicators Turning Favorable:

      Oscillators such as the Relative Strength Index (RSI) have cooled down from overbought conditions back to neutral zones (~50–55 level), paving the way for the next leg of the upward move.

    Trade Setup & Key Levels

    • Entry Range: ₹580 – ₹585

    • Target Price: ₹615 – ₹625 (Short-term horizon: 2 to 3 weeks)

    • Stop Loss: ₹565 (Closing basis below the 50-DMA)

    Fundamental Backing

    • Strong Earnings Momentum: Star Health reported a 44% YoY jump in normalized PAT to ₹386 crore for Q1 FY27, backed by a sharp recovery in underwriting profits to ₹111 crore.

    • Network Expansion: Continued expansion across its hospital network along with a 13–15% growth trajectory in Gross Written Premiums (GWP) provides long-term fundamental support to the technical recovery.

    (Disclaimer: Recommendations, suggestions, and views given by market analysts represent their own opinions and do not reflect the views of financial institutions or platforms. Traders should consult certified experts before placing trades.)

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous Article‘In God We Trust, All Others Pay Cash’: Warren Buffett Had the Cash and Still Has It
    Next Article Pirojsha Godrej Takes Charge at Godrej Industries: Key Takeaways & Strategic Growth Plan
    Aruna Kaim

    Related Posts

    Market Caution & Strategic Stock Selection: Large- and Mid-Cap Opportunities with 20%+ Upside

    October 17, 2026

    The ESOP Muddle: How Equity Compensation Can Distort Financials and Disadvantage Minority Shareholders

    October 17, 2026

    Navigating Market Volatility: 5 Stocks with Consistent Score Improvements and Up to 29% Upside Potential

    October 17, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Market Caution & Strategic Stock Selection: Large- and Mid-Cap Opportunities with 20%+ Upside

    October 17, 2026

    The ESOP Muddle: How Equity Compensation Can Distort Financials and Disadvantage Minority Shareholders

    October 17, 2026

    Navigating Market Volatility: 5 Stocks with Consistent Score Improvements and Up to 29% Upside Potential

    October 17, 2026
    Advertisement
    Demo

    Your source for the serious news. This demo is crafted specifically to exhibit the use of the theme as a news site. Visit our main page for more demos.

    We're social. Connect with us:

    Facebook X (Twitter) Instagram Pinterest YouTube
    Recend Posts
    • Rising Borrowing Costs Signal Funding Risks for Global AI Expansion: Jefferies Report
    • Househelp@₹100: The 10-Minute Boom Can’t Sweep Aside a Math Problem
    • Prem Watsa’s Grand Vision: Riding India’s Decade of Growth Through the IDBI Bank Acquisition
    • Strategic Divestment: Swiggy Completes Sale of Lynks Logistics to Trustroot Internet
    • Scaling India’s Consumer Brands: Insights from thecc Bharat D2C Conclave 2026
    Contact Us

    Varta24 Business
    India International Centre
    40, Max Mueller Marg
    Lodhi Estate, New Delhi-110003
    Email.varta24live@gmail.com

    © 2026 Varta24 Media, Designed by Social Fox.
    • Home
    • Markets
    • Stocks
    • Funds
    • Buy Now

    Type above and press Enter to search. Press Esc to cancel.